These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

250 related items for PubMed ID: 6289314

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Apolipoprotein E2(Arg158----Cys) frequency in a hyperlipidemic French-Canadian population of apolipoprotein E2/2 subjects. Determination by synthetic oligonucleotide probes.
    Weisgraber KH, Newhouse YM, Taylor JM, Tuan B, Nestruck AC, Davignon J, Mahley RW.
    Arteriosclerosis; 1989; 9(1):50-7. PubMed ID: 2912421
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Apolipoprotein E polymorphism in health and disease.
    Utermann G.
    Am Heart J; 1987 Feb; 113(2 Pt 2):433-40. PubMed ID: 3544759
    [Abstract] [Full Text] [Related]

  • 9. Apolipoprotein E2 (Arg-136-->Cys), a variant of apolipoprotein E associated with late-onset dominance of type III hyperlipoproteinaemia.
    Feussner G, Albanese M, Mann WA, Valencia A, Schuster H.
    Eur J Clin Invest; 1996 Jan; 26(1):13-23. PubMed ID: 8682150
    [Abstract] [Full Text] [Related]

  • 10. A novel electrophoretic variant of human apolipoprotein E. Identification and characterization of apolipoprotein E1.
    Weisgraber KH, Rall SC, Innerarity TL, Mahley RW, Kuusi T, Ehnholm C.
    J Clin Invest; 1984 Apr; 73(4):1024-33. PubMed ID: 6323533
    [Abstract] [Full Text] [Related]

  • 11. [Apolipoprotein E and its alleles in healthy subjects and in atherosclerosis].
    Couderc R, Bailleul S.
    Ann Biol Clin (Paris); 1998 Apr; 56(6):651-9. PubMed ID: 9853024
    [Abstract] [Full Text] [Related]

  • 12. Apolipoprotein E2-Christchurch (136 Arg----Ser). New variant of human apolipoprotein E in a patient with type III hyperlipoproteinemia.
    Wardell MR, Brennan SO, Janus ED, Fraser R, Carrell RW.
    J Clin Invest; 1987 Aug; 80(2):483-90. PubMed ID: 3038959
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. High receptor binding affinity of lipoproteins in atypical dysbetalipoproteinemia (type III hyperlipoproteinemia).
    Chappell DA.
    J Clin Invest; 1989 Dec; 84(6):1906-15. PubMed ID: 2556448
    [Abstract] [Full Text] [Related]

  • 17. Influence of apolipoprotein E polymorphism on plasma lipid and apolipoprotein levels, and clinical characteristics of type III hyperlipoproteinemia due to apolipoprotein E phenotype E2/2 in Japan.
    Kobori S, Nakamura N, Uzawa H, Shichiri M.
    Atherosclerosis; 1988 Jan; 69(1):81-8. PubMed ID: 3355609
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Apolipoprotein E3-Leiden. A new variant of human apolipoprotein E associated with familial type III hyperlipoproteinemia.
    Havekes L, de Wit E, Leuven JG, Klasen E, Utermann G, Weber W, Beisiegel U.
    Hum Genet; 1986 Jun; 73(2):157-63. PubMed ID: 3721502
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 13.